Dividends & Buybacks ·
MariMed proposes reverse stock split of up to one-for-100 to meet exchange listing requirements
MRMDMarimed Inc.
MariMed Inc. filed a definitive proxy statement to seek stockholder approval for a proposed reverse stock split at its Special Meeting scheduled for October 28, 2026. The Board has authorized the implementation of a split with a ratio between one-for-fifty and one-for-one-hundred, pending final determination based on market conditions and exchange listing requirements. This corporate action aims to increase the common stock's price to satisfy minimum bid price rules for a potential listing on a U.S. national securities exchange, thereby broadening access to institutional investors and capital markets. Fractional shares resulting from the split would be cashed out rather than issued. MariMed Inc. is a leading multi-state cannabis operator focused on cultivation, production, and retail.